BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 24907488)

  • 1. Clostridium difficile infection among immunocompromised patients in Rio de Janeiro, Brazil and detection of moxifloxacin resistance in a ribotype 014 strain.
    Secco DA; Balassiano IT; Boente RF; Miranda KR; Brazier J; Hall V; dos Santos-Filho J; Lobo LA; Nouér SA; Domingues RM
    Anaerobe; 2014 Aug; 28():85-9. PubMed ID: 24907488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of cross-infection associated to a Brazilian PCR-ribotype of Clostridium difficile in a university hospital in Rio de Janeiro, Brazil.
    Balassiano IT; dos Santos-Filho J; Vital-Brazil JM; Nouér SA; Souza CR; Brazier JS; Ferreira Ede O; Domingues RM
    Antonie Van Leeuwenhoek; 2011 Feb; 99(2):249-55. PubMed ID: 20623188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Clostridium difficile strains isolated from immunosuppressed inpatients in a hospital in Rio de Janeiro, Brazil.
    Balassiano IT; Miranda KR; Boente RF; Pauer H; Oliveira IC; Santos-Filho J; Amorim EL; Caniné GA; Souza CF; Gomes MZ; Ferreira EO; Brazier JS; Domingues RM
    Anaerobe; 2009 Jun; 15(3):61-4. PubMed ID: 19154793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].
    Poilane I; Fantinato C; Cruaud P; Collignon A
    Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of Clostridium difficile PCR-ribotype 027 and it's closely related PCR-ribotype 176 in hospitals in Poland in 2008-2010.
    Obuch-Woszczatyński P; Lachowicz D; Schneider A; Mól A; Pawłowska J; Ożdżeńska-Milke E; Pruszczyk P; Wultańska D; Młynarczyk G; Harmanus C; Kuijper EJ; van Belkum A; Pituch H
    Anaerobe; 2014 Aug; 28():13-7. PubMed ID: 24799338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First clinical and microbiological characterization of Clostridium difficile infection in a Croatian University Hospital.
    Novak A; Spigaglia P; Barbanti F; Goic-Barisic I; Tonkic M
    Anaerobe; 2014 Dec; 30():18-23. PubMed ID: 25079669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis.
    Nyc O; Tejkalova R; Kriz Z; Ruzicka F; Kubicek L; Matejkova J; Kuijper E; Krutova M
    Microb Drug Resist; 2017 Jul; 23(5):609-615. PubMed ID: 27860531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.
    Lachowicz D; Pituch H; Obuch-Woszczatyński P
    Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The characteristics of Clostridium difficile ST81, a new PCR ribotype of toxin A- B+ strain with high-level fluoroquinolones resistance and higher sporulation ability than ST37/PCR ribotype 017.
    Wang B; Peng W; Zhang P; Su J
    FEMS Microbiol Lett; 2018 Sep; 365(17):. PubMed ID: 30085003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of Clostridium difficile ribotype 027 in hospitals of Silesia, Poland.
    Aptekorz M; Szczegielniak A; Wiechuła B; Harmanus C; Kuijper E; Martirosian G
    Anaerobe; 2017 Jun; 45():106-113. PubMed ID: 28216085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology of Clostridium difficile infection in a Brazilian cancer hospital.
    Costa CL; Mano de Carvalho CB; González RH; Gifoni MAC; Ribeiro RA; Quesada-Gómez C; Brito GAC
    Anaerobe; 2017 Dec; 48():232-236. PubMed ID: 28987390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes.
    Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren AC; Weintraub A; Nord CE
    Int J Antimicrob Agents; 2009 Apr; 33(4):339-42. PubMed ID: 19097757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between PCR ribotypes and antimicrobial susceptibility among Clostridium difficile isolates from healthcare-associated infections in South Korea.
    Kim J; Kang JO; Pai H; Choi TY
    Int J Antimicrob Agents; 2012 Jul; 40(1):24-9. PubMed ID: 22578765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory diagnosis of Clostridium difficile associated diarrhoea and molecular characterization of clinical isolates.
    Russello G; Russo A; Sisto F; Scaltrito MM; Farina C
    New Microbiol; 2012 Jul; 35(3):307-16. PubMed ID: 22842600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antibiotic susceptibility profile of Clostridium difficile excluding PCR ribotype 027 outbreak strain in Hungary.
    Terhes G; Maruyama A; Latkóczy K; Szikra L; Konkoly-Thege M; Princz G; Nagy E; Urbán E
    Anaerobe; 2014 Dec; 30():41-4. PubMed ID: 25150212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile ribotype 176 - A predictor for high mortality and risk of nosocomial spread?
    Polivkova S; Krutova M; Petrlova K; Benes J; Nyc O
    Anaerobe; 2016 Aug; 40():35-40. PubMed ID: 27155489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility and heteroresistance in Chinese Clostridium difficile strains.
    Huang H; Weintraub A; Fang H; Wu S; Zhang Y; Nord CE
    Anaerobe; 2010 Dec; 16(6):633-5. PubMed ID: 20849968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013.
    Pituch H; Obuch-Woszczatyński P; Lachowicz D; Wultańska D; Karpiński P; Młynarczyk G; van Dorp SM; Kuijper EJ;
    Euro Surveill; 2015; 20(38):. PubMed ID: 26536049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon.
    Berger FK; Rasheed SS; Araj GF; Mahfouz R; Rimmani HH; Karaoui WR; Sharara AI; Dbaibo G; Becker SL; von Müller L; Bischoff M; Matar GM; Gärtner B
    Int J Med Microbiol; 2018 Apr; 308(3):358-363. PubMed ID: 29478838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology and resistance profiles of Clostridium difficile in a tertiary care hospital in Spain.
    Weber I; Riera E; Déniz C; Pérez JL; Oliver A; Mena A
    Int J Med Microbiol; 2013 Apr; 303(3):128-33. PubMed ID: 23523477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.